Clinical Application and Technical Considerations for the Use of Contrast Agents in the Echocardiography Laboratory

Abstract

Contrast imaging represents a new and exciting application to the field of ultrasonography. As with the introduction of new imaging modes (i.e., color flow imaging) or examination (i.e., stress echocardiog-raphy), a learning phase will be necessary. For optimal contrast use, it is important to understand what microbubbles are designed to enhance, how to optimize the imaging system, and how to interpret the resulting images. Types of administration and use of the agents are also important to understand. This article will offer technical tips and helpful hints to shorten the sonographer's learning curve to successfully implement optimal contrast imaging for cardiac applications.

Keywords

contrast echocardiography technical applications

References

Gramiak R , Shah PM : Echocardiography of the aortic root. Invest Radiol 1968;3:356–366.

Geny B , Mettauer B , Muan B ,et al: Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. J Am Coll Cardiol 1993;22:1193–1198.

Porter T , Xie F , Kriesfeld A , Chiou A , Dabestani A : Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol 1994;23:1440–1443.

Leischik R , Kuhlmann C , Bruch C , Jeremias A , Buck T , Erbel R : Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (BY 963). Int J Cardiac Imaging 1997;13:387–394.

Feinstein S , Cheirif J , Ten Cate F ,et al: Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 1990;16:316–324.

Falcone R , Marcovitz P , Perez J , Dittrich H , Hopkins W , Armstrong W : Intravenous Albunex during dobutamine stress echocardiography: enhanced localization of left ventricular endocardial borders. Am Heart J 1995;130:254–258.

Hutter JC , Luu HM , Mehlaff PM , Killam AL , Dittrich HC : Physiologically based pharmacokinetic model for fluorocarbon elimination after the administration of an octafluoropropane-albumin microsphere sonographic contrast agent. J Ultrasound Med 1999;18:1–11.

Kuecherer HF , Will M , da Silva KG ,et al: Contrast-enhanced Doppler ultrasound for noninvasive assessment of pulmonary artery pressure during exercise in patients with chronic congestive heart failure. Am J Cardiol 1996;78:229–232.

Nahar T , Croft L , Shapiro R ,et al: Comparison of four echocardiographic techniques for measuring left ventricular ejection fraction. Am J Cardiol 2000;86:1358–1362.

10.

Reilly JP , Tunick PA , Timmermans RJ , Stein B , Rosenzweig BP , Krozon I : Contrast echocardiography clarifies uninter pretable wall motion in intensive care unit patients. J Am Coll Cardiol 2000;35:485–490.

11.

Ikonomidis I , Holmes E , Narbuvold H , Bolstad B , Muan B , Nihoyannopoulos P . Assessment of left ventricular wall motion and delineation of the endocardial border after intravenous injection of Infoson during dobutamine stress echocardiography. Coronary Artery Dis 1998;9:567–576.

12.

Yvorchuk K , Sochowski R , Chan K : Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization. J Am Soc Echocardiogr 1996;9:462–469.

13.

Schroder K , Agrawal R , Voller H , Schlief R , Schroder R : Improvement of endocardial border delineation in suboptimal stress-echocardiogram using the new left heart contrast agent SH U 508. Int J Cardiac Imaging 1994;10:45–51.

14.

Mulvagh SL , DeMaria AN , Feinstein SB ,et al: Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 2000;13:331–342.

15.

Shaw LJ , Gillam L , Feinstein S , Dent J , Plotnick G : Use of intravenous sontrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Am J Managed Care 1998;25:169–176.

16.

Izumi C , Yoshida K , Akasaka T , Hozumi T , Miyake S , Yoshikawa J : Improved visualization of pulmonary venous flow Doppler signal by intravenous injection of sonicated albumin. Am J Cardiol 1996;78:598–600.

17.

Okura H , Yoshida K , Akasaka T ,et al: Improved transvalvular continuous-wave Doppler signal intensity after intravenous Albunex injection in patients with prosthetic aortic valves. J Am Soc Echocardiogr 1997;10:608–612.

18.

Firschke C , Koberl B , von Bibra H , Horcher J , Schomig A : Combined use of contrast-enhanced 2-dimensional and color Doppler echocardiography for improved left ventricular endocardial border delineation using Levovist, a new venous echocardiographic contrast agent. Int J Cardiac Imaging 1997;13:137–144.

19.

Bach DS : Adherence of Albunex to an apical left ventricular thrombus. J Am Soc Echocardiogr 1999;12:761–762.

20.

Thanigaraj S , Schectman KB , Perez JE : Improved echocardiographic delineation of left ventricular thrombus with the use of intravenous second generation contrast image enhancement. J Am Soc Echocardiogr 1999;12:1022–1026.

21.

Waggoner AD , Williams GA , Gaffron D , Schwarze M : Potential utility of left heart contrast agents in diagnosis of myocardial rupture by 2-dimensional echocardiography. J Am Soc Echocardiogr 1999;12:272–274.

22.

Kriahna PD , Newhouse VL : Second harmonic characteristics of the ultrasound contrast agents Albunex and FSO69. Ultrasound Med Biol 1997;23:453–459.

23.

Greener Y , Killam AL , Goenechea J , Dittrich HC , Beecher H : In vitro, animal and human characterization of Optison infusions for myocardial contrast echo. J Am Soc Echocardiogr 1999;12:1027–1034.

24.

Weissman NJ , Cohen MC , Hack TC , Gillam LD , Cohen JL , Kitzman DW : Infusion versus bolus contrast echocardiography: a multicenter, open-label, crossover trial. Am Heart J 2000;139:399–404.

25.

Lindner JR , Villanueva FS , Dent JM , Wei K , Sklenar J , Kaul S : Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. Am Heart J 2000;139:231–240.

26.

Wei K , Jayaweera AR , Firoozan S , Linka A , Skyba DM , Kaul S : Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? J Am Coll Cardiol 1998;32:252–260.

27.

Villarraga HR , Foley DA , Aeschbacher BC , Klarich KW , Mulvagh SL : Destruction of contrast microbubbles during ultrasound imaging at conventional power output. J Am Soc Echocardiogr 1997;10:783–791.

28.

Senior R , Kaul S , Soman P , Lahiri A : Power Doppler harmonic imaging: a feasibility study of a new technique for the assessment of myocardial perfusion. Am Heart J 2000;139(2 pt 1):245–251.

29.

Linka AZ , Sklenar J , Wei K , Jayaweera AR , Skyba DM , Kaul S : Assessment of transmural distribution of myocardial perfusion with contrast echocardiography. Circulation 1998;98: 1912–1920.

30.

Lepper W , Hoffman R , Kamp O ,et al: Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty (correction of angiography) in patients with acute myocardial infarction. Circulation 2000;101:2368–2374.

31.

Masugata H , Peters B , Lafitte S , Strachan GM , Ohmori K , DeMaria AN : Quantitative assessment of myocardial perfusion during graded coronary stenosis by real-time myocardial contrast echo refilling curves. J Am Coll Cardiol 2001;37: 262–269.

32.

Porter TR , Li S , Jiang L , Grayburn P , Deligonul U : Real-time visualization of myocardial perfusion and wall thickening in human beings with intravenous ultrasonographic contrast and accelerated intermittent harmonic imaging. J Am Soc Echocardiogr 1999;12:266–271.